Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;30(3):332-337.
doi: 10.1016/j.jagp.2021.07.012. Epub 2021 Jul 29.

Increased Levels of Circulating Cell-Free mtDNA in the Plasma of Subjects With Late-Life Depression and Frailty: A Preliminary Study

Affiliations

Increased Levels of Circulating Cell-Free mtDNA in the Plasma of Subjects With Late-Life Depression and Frailty: A Preliminary Study

Emi Ampo et al. Am J Geriatr Psychiatry. 2022 Mar.

Abstract

Objective: To evaluate the circulating cell-free mitochondrial DNA (ccf-mtDNA) levels, a marker of cellular stress and damage, in older adults with late-life depression (LLD) and frailty. We hypothesize that individuals with both frailty and LLD will have higher ccf-mtDNA levels than individuals with either condition in isolation.

Methods: Fifty-three older adults (Never Depressed+Robust (reference group, n = 16), LLD+Robust (n = 9), Never Depressed+Prefrail/Frail (n = 5), and LLD+Prefrail/Frail (n = 23)) were included in the study. DNA was extracted from EDTA plasma samples, and ccf-mtDNA was quantified by RT-PCR.

Results: We found a statistically significant difference in the levels of ccf-mtDNA across groups (F(3,49) = 3.07, p = 0.036), with individuals in the LLD+Prefrail/Frail group showing the highest levels of ccf-mtDNA.

Conclusion: The coexistence of LLD and frailty is associated with increased markers of cellular damage and stress (i.e., ccf-mtDNA). Our results suggest that these conditions may share cellular stress and mitochondrial dysfunction phenomena as a common biological mechanism, offering potential future opportunities for geroscience-guided interventions for these conditions.

Keywords: Late-life depression; aging; cellular stress; circulating cell-free mitochondrial DNA; frailty; mitochondria dysfunction.

PubMed Disclaimer

Conflict of interest statement

Statement of conflict of interest

All authors do not report any conflict of interest related to this manuscript.

Comment in

References

    1. Brown PJ, Roose SP, O’Boyle KR, et al.: Frailty and Its Correlates in Adults With Late Life Depression. Am J Geriatr Psychiatry 2019; 14:145–154. - PMC - PubMed
    1. Brown PJ, Rutherford BR, Yaffe K, et al.: The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging. Am J Geriatr Psychiatry 2016; 24:1084–1094. - PMC - PubMed
    1. Arts MHL, van den Berg KS, Marijnissen RM, et al.: Frailty as a Predictor of Mortality in Late-Life Depression: A Prospective Clinical Cohort Study. J Clin Psychiatry 2021; 82:20m13277. - PubMed
    1. Diniz BS, Lin C, Sibille E, et al.: Circulating biosignatures of late-life depression (LLD): Towards a comprehensive, data-driven approach to understanding LLD pathophysiology. J Psychiatr Res 2016; 82:1–7. - PMC - PubMed
    1. López-Otín C, Blasco MA, Partridge L, et al.: The hallmarks of aging. Cell 2013; 153:1194–217. - PMC - PubMed

Publication types